D61.810 - Antineoplastic chemotherapy induced pancytopenia

Applicable to Antineoplastic chemotherapy induced pancytopenia
The 2025 edition of ICD10-CM D61.810 became effective on October 1, 2024.
This is the American ICD10-CM version of D61.810 - other international versions of ICD10 D61.810 may differ.
D61.810 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Type 2 Excludes

aplastic anemia due to antineoplastic chemotherapy (D61.1)

The following codes above D61.810 contain annotation back-references that may be applicable to D61.810:

Chapter: D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Section: D60-D64 Aplastic and other anemias and other bone marrow failure syndromes

Category: D61 Other aplastic anemias and other bone marrow failure syndromes

chemotherapy icd 10

disorders icd 10

antineoplastic icd 10

mechanism icd 10

pancytopenia icd 10

syndromes icd 10

aplastic icd 10

Billable/Specific Code

Browse other similar CM codes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Please, give attribution to our website icd-10code.com